August 24, 2012
ViiV Healthcare Co. and Vertex Pharmaceuticals Inc. slapped Mylan Inc. with a patent infringement lawsuit in Delaware on Wednesday over Mylan's bid for U.S. regulatory approval to make and sell a generic version of the anti-HIV drug Lexiva.